Skip to content
etf.net

Launched · SEC filings

Invesco S&P SmallCap Health Care ETF

PSCHNasdaqInvescoB

$55.33−0.36 (−0.65%)

At close: Nov 2, 2026, 4:00 PM ET

B67/ 100

Rank 8 of 25 in Health Care (Broad)

B67/100Rank 8 of 25inHealth Care (Broad)
Intraday session: down, 79 prints from 55.69 to 55.33. Range 55.33 to 56.12. Use the arrow keys to read each point.55.6055.8056.0010 AM12 PM2 PM4 PM
Expense ratio
0.29%
Fund size
$179M
1Y total return
+31.6%
Yield · Last 12 months
0.00%
Holdings
72
Avg volume · 30D
25.8K sh
52W range
low $39.08high $56.65
Launched
Filings
SEC EDGAR

The ETF.net PSCH Grade

Based on 5 of 6 pillars

B

Score 67 out of 100

Category
Health Care (Broad)⁠
Rank
8 of 25
Six-pillar profile for PSCH. Scores out of 100: Cost 88, Risk 49, Mission not scored, Tradability 45, Holdings 73, Durability 62. Strongest: Cost (88). Weakest: Tradability (45). Based on 5 of 6 pillars.

Score 67 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A88 out of 100
    Rank 4 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    C49 out of 100
    Rank 13 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C45 out of 100
    Rank 14 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A73 out of 100
    Rank 8 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B62 out of 100
    Rank 13 of 25

Our read on PSCH

ETF.net Research

In short

BHealth care, minus the mega-cap pharma giants. PSCH tracks a capped small-cap health care index from the S&P SmallCap 600: roughly 70 companies, same sector as the household-name funds, opposite end of the size spectrum, for 0.29% a year.

Stated mandate

The Fund is based on the S&P SmallCap 600® Capped Health Care Index and normally invests at least 90% of its assets in securities represented by that Index.

Why people hold it

  • Charges 0.29% a year, well below the median fee in its broad health care peer group. Cheap access to the small-cap corner of the sector.
  • Rules-based and plain: normally at least 90% of assets in the securities of the S&P SmallCap 600 Capped Health Care Index, roughly 70 names, with index caps limiting how large any one position gets.
  • Running since 2010, through multiple biotech boom-and-bust cycles, and one of the stronger builds among the two dozen broad health care ETFs we track.

Worth knowing

  • Trades lightly next to the mega-cap sector funds, so bid-ask spreads and market impact matter more here, particularly in size or in a fast-moving market.
  • Small-cap health care is the jumpy end of the sector, and a roughly 70-stock lineup means single-company news lands harder than in a sprawling mega-cap fund.
  • Distributions come once or twice a year, not monthly. This is a sector equity sleeve, not an income-first holding.

PSCH Holdings

Holdings pillarA73 out of 100Rank 8 of 25 in Health Care (Broad)
Asset class
Stocks
Holdings
72
Top-10 weight
36%
Largest holding
GKOS7.1%

Sectors

  • Health Care98.8%
  • Financials1.2%

Geography

  • United States100.00%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1GKOSGlaukos Corp7.14%53,639$13M131
2PTGXProtagonist Therapeutics Inc4.67%58,855$8.5M152
3TGTXTG Therapeutics Inc4.12%129,019$7.49M132
4ALKSAlkermes PLC3.80%152,529$6.92M152
5LGNDLigand Pharmaceuticals Inc3.16%18,117$5.75M139
6TFXTeleflex Inc2.99%38,505$5.44M113
7MMSIMerit Medical Systems Inc2.78%54,258$5.07M134
8PTCTPTC Therapeutics Inc2.69%75,891$4.89M129
9RDNTRadNet Inc2.60%64,378$4.74M117
10CONConcentra Group Holdings Parent Inc2.44%107,836$4.45M137
11ITGRInteger Holdings Corp2.15%30,917$3.91M103
12ICUIICU Medical Inc2.11%22,725$3.83M113
13VCYTVeracyte Inc2.09%73,020$3.81M143
14INDVIndivior Pharmaceuticals Inc2.08%107,202$3.78M133
15AMRXAmneal Pharmaceuticals Inc1.97%167,901$3.58M136

Showing 1–15 of 72 holdings

PSCH Performance

Launched Apr 7, 2010

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

PSCH$13,156
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. PSCH $13,156. SPY $11,199. Use the arrow keys to read each point.$10,000$12,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PSCH. Periods over one year show the average yearly return.
PeriodPSCH
Year to date+26.4%
1 month+7.0%
3 months+4.3%
1 year+31.6%
3 yearsper year+16.3%
5 yearsper year−1.7%
10 yearsper year+9.6%

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PSCH
YearReturn barPSCH
2026 YTD+26.4%
2025−0.5%
2024+3.8%
2023−2.7%

PSCH in the news

PSCH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.00%Last 12 months
Payout per share
$0.00033Last 12 months
Last payment
$0.00033 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Twice a year

Distribution history

2017–2026

One bar per payment. 9 payments from 2017 to 2026 YTD. Sep 24, 2018 $0.0017; Dec 18, 2023 $0.0045; Mar 18, 2024 $0.04; Jun 24, 2024 $0.07; Dec 23, 2024 $0.02; Mar 24, 2025 $0.01; Jun 23, 2025 $0.002; Sep 22, 2025 $0.0026; Mar 23, 2026 $0.00033. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Mar 23, 2026Mar 27, 2026$0.00033
Sep 22, 2025Sep 26, 2025$0.0026
Jun 23, 2025Jun 27, 2025$0.002
Mar 24, 2025Mar 28, 2025$0.01
Dec 23, 2024Dec 27, 2024$0.02
Jun 24, 2024Jun 28, 2024$0.07
Mar 18, 2024Mar 22, 2024$0.04
Dec 18, 2023Dec 22, 2023$0.0045
Sep 24, 2018Sep 28, 2018$0.0017
Dec 16, 2016Dec 30, 2016$0.0065
Dec 24, 2014Dec 31, 2014$0.48
Dec 19, 2014Dec 31, 2014$0.0092

See all 19 payments⁠

$10,000 in PSCH 10 years ago paid $70.98 in dividends.⁠

PSCH Risk

Risk pillarC49 out of 100Rank 13 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
21.3%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.61
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−45.8%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.96
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

PSCH Cost

Compare PSCH and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$4,263

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • PSCH 0.29%

    $5,952

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • PSCH 0.29%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K051015202530PSCH $5,952XLV $1,689

Year by year

YearPSCHXLVOverpaying
10$527$147$380
20$2,044$575$1,469
30$5,952$1,689$4,263

Other funds in Health Care (Broad)

See others